![](/img/cover-not-exists.png)
Clinical Utility of Measuring Infliximab (IFX) and Adalimumab (ADA) and Anti-drug Antibody Levels Using the LabCorp Assay in Patients With Inflammatory Bowel Disease (IBD)
Brown, Sara, Perinbasekar, Rajiv, Syed, Nauroz, Lonsako, Shumet, Cross, RaymondVolume:
112
Journal:
American Journal of Gastroenterology
DOI:
10.14309/00000434-201710001-00735
Date:
October, 2017
File:
PDF, 115 KB
2017